{{Rsnum
|rsid=3918241
|Gene=MMP9
|Chromosome=20
|position=46007096
|Orientation=plus
|GMAF=0.1488
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene_s=MMP9
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 6.2 | 29.2 | 64.6
| HCB | 0.0 | 20.0 | 80.0
| JPT | 4.5 | 27.3 | 68.2
| YRI | 3.2 | 27.0 | 69.8
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 20.0 | 80.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20181264
|Title=MMP-9 gene variants increase the risk for non- atopic asthma in children
|OA=1
}}

{{PMID Auto
|PMID=20725776
|Title=MMP9 polymorphisms and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study
|OA=1
}}

{{PMID Auto
|PMID=18636124
|Title=Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma.
|OA=1
}}

{{PMID Auto
|PMID=20078883
|Title=Association of MMP-2 polymorphisms with severe and very severe COPD: a case control study of MMPs-1, 9 and 12 in a European population.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}